Browsing Tag
Swiss biotech
1 post
Why did Newron Pharmaceuticals stock rise by nearly 8% and what triggered investor enthusiasm?
Newron Pharmaceuticals stock rallies 7.88% after evenamide schizophrenia trial data and WCBP presentations highlight breakthrough potential. Read what’s next for investors.